LEGOCHEM BIOSCIENCES ANNOUNCES LICENSE AGREEMENT FOR LCB84 TROP2-TARGETED ADC LegoChem Biosciences to receive up to potentially USD1.7 billion in total, including an upfront payment and option exercise fee (December 26, 2023) | By DAEJEON, South Korea–(BUSINESS WIRE). LegoChem Biosciences to receive up to potentially USD1.7 billion in total, including an upfront payment and option exercise
Sanofi signs $140m small molecule discovery deal with Aqemia The multi-year research collaboration will involve Aqemia’s AI platform, with the company receiving up to $140m from Sanofi. (December 5, 2023) | By Jenna Philpott. Sanofi has entered a multi-year research collaboration deal with French pharmatech Aqemia to develop small molecule drug candidates for several different
